Preoperative Sleep Quality and Postoperative Outcomes in Breast Surgery
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexFemale
Age18-70
SponsorDr Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital
About this trial
Sleep quality is a key physiological factor influencing immune function, inflammatory response, and pain perception. This prospective observational study aims to evaluate whether preoperative sleep quality predicts postoperative inflammation, pain severity, and analgesic consumption in patients undergoing elective breast cancer surgery.
Preoperative sleep quality will be assessed using the Pittsburgh Sleep Quality Index (PSQI). Systemic inflammatory response will be evaluated using the Systemic Immune-Inflammation Index (SII), calculated from routine hematological parameters. Postoperative pain will be assessed using the Visual Analog Scale (VAS), and analgesic consumption will be recorded within the first 24 hours.
The study aims to determine whether poor sleep quality is associated with increased inflammatory response, higher pain scores, and greater analgesic requirement.
Eligibility criteria
Qualifiers
Female patients aged 18 to 70 years
Scheduled for elective breast cancer surgery
American Society of Anesthesiologists (ASA) physical status I to III
Able to understand and complete the Pittsburgh Sleep Quality Index (PSQI)
Disqualifiers
Active infection
History of chronic inflammatory disease or autoimmune disease
Use of steroids or immunosuppressive drugs within the past 6 months
Known diagnosis of obstructive sleep apnea syndrome
Trial design
Treatments tested in this trial
- Preoperative Sleep Quality Assessment (PSQI)
Treatment groups
150 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov